open access

Vol 71, No 2 (2020)
Clinical vignette
Submitted: 2019-11-04
Accepted: 2019-11-10
Published online: 2020-02-25
Get Citation

Long-term remission of steroid-resistant Graves’ orbitopathy after administration of anti-thymocyte globulin

Maria Świerkot1, Grażyna Kulawik1, Monika Sarnat-Kucharczyk2, Krystyna Jagoda3, Ewa Mrukwa-Kominek2, Jerzy Chudek1
·
Pubmed: 32096552
·
Endokrynol Pol 2020;71(2):198-199.
Affiliations
  1. Endocrinology Unit, Department of Internal Medicine and Oncological Chemotherapy, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
  2. Department of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
  3. Department of Haematology and Bone Marrow Transplantation, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland

open access

Vol 71, No 2 (2020)
Clinical Vignette
Submitted: 2019-11-04
Accepted: 2019-11-10
Published online: 2020-02-25

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

Graves’ orbitopathy; anti-thymocyte globulin; dysthyroid optic neuropathy

About this article
Title

Long-term remission of steroid-resistant Graves’ orbitopathy after administration of anti-thymocyte globulin

Journal

Endokrynologia Polska

Issue

Vol 71, No 2 (2020)

Article type

Clinical vignette

Pages

198-199

Published online

2020-02-25

Page views

1410

Article views/downloads

759

DOI

10.5603/EP.a2019.0067

Pubmed

32096552

Bibliographic record

Endokrynol Pol 2020;71(2):198-199.

Keywords

Graves’ orbitopathy
anti-thymocyte globulin
dysthyroid optic neuropathy

Authors

Maria Świerkot
Grażyna Kulawik
Monika Sarnat-Kucharczyk
Krystyna Jagoda
Ewa Mrukwa-Kominek
Jerzy Chudek

References (6)
  1. Bartalena L, Baldeschi L, Boboridis K, et al. European Group on Graves' Orbitopathy (EUGOGO). The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur Thyroid J. 2016; 5(1): 9–26.
  2. Kahaly GJ, Shimony O, Gellman YN, et al. Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin. J Clin Endocrinol Metab. 2011; 96(2): 422–429.
  3. Zand MS, Vo T, Huggins J, et al. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation. 2005; 79(11): 1507–1515.
  4. Gurkan S, Luan Y, Dhillon N, et al. Immune reconstitution following rabbit antithymocyte globulin. Am J Transplant. 2010; 10(9): 2132–2141.
  5. Lee Y, Butani L, Glaser N, et al. Resolution of Graves' disease after renal transplantation. Pediatr Transplant. 2016; 20(4): 590–593.
  6. Blandford AD, Zhang D, Chundury RV, et al. Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management. Expert Rev Ophthalmol. 2017; 12(2): 111–121.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl